ProSALUTE: Community Program for Cardiovascular Health

Assessed as rate of primary adherence according to educational level (years of schooling <8, 8-12 or >12)

Assessed as rate of primary adherence according to working category (manual worker, service worker, office worker, unemployed, retired)

Assessed as rate of primary adherence according to immigrant (from any country) or native status

Awareness assessed as prevalence of knowledge (answer: known value or not known) of levels of the following personal cardiovascular risk factors: total cholesterol, triglycerides, glycaemia, systolic and diastolic blood pressure

Accuracy assessed as concordance (using Cohen's kappa test) between risk perception (evaluated through a 5 point Likert scale questionnaire: from very low to very high) and estimated cardiovascular risk (evaluated through the Framingham Risk Score)

Anxiety assessed using General Anxiety Disorder 2 (GAD-2) test and defined as positive with a score ≥3

Depressive mood assessed using Patient Health Questionnaire 2 (PHQ-2) test and defined as positive with a score ≥3

Extent of adherence to MD assessed using the PREDIMED questionnaire and score, using three categories (0-7 low adherence; 8-9 medium adherence, ≥10 high adherence)

Physical activity (PA) assessed using the PASSI questionnaire and physically active subjects defined according to the WHO 2010 Guidelines

Percent of enrolled subjects allocated to medical visit, interview with nutritionist, motivational interview to promote physical activity, smoking-cessation program, interview with psychologist

Persistence assessed as the ratio between subjects followed at 6 months and subjects enrolled

Assessed as the net improvement in category of adherence to MD (number of those who increased minus number of those who decreased)

Assessed as the net improvement in category of PA level (number of sedentary subjects shifted to active or moderate minus number of active or moderate shifted to sedentary)

Assessed as the net improvement in extent of cigarette consumption (number of smokers who reduced the number of cigarettes/day minus number of smokers who increased the number of cigarettes/day)

Assessed as the net improvement in exhaled Carbon Monoxide (CO) (number of smokers who reduced ≥10% exhaled CO ppm minus number of smokers who increased ≥10% exhaled CO ppm)

Assessed as the net improvement in screening for anxiety (number of positive who became negative minus number of negative who became positive)

Assessed as the net improvement in screening for depression (number of positive who became negative minus number of negative who became positive)

Assessed as the number of subjects who improved by ≥10% at least one traditional CV risk factor measure without worsening by ≥10% any other CV risk factor measure. The CV risk factors considered are: glycaemia >126 mg/dl, LDL-C >115 mg/dl, systolic blood pressure >140 mmHg and BMI >28

Assessed as net improvement in Framingham Risk Score (number of subjects who reduced the score minus number of subjects who increased the score)

Persistence assessed as the ratio between subjects followed at 12 months and subjects enrolled

Assessed as the number of subjects who improved by ≥10% at least one traditional CV risk factor measure without worsening by ≥10% any other CV risk factor measure. The CV risk factors considered are: glycaemia >126 mg/dl, LDL-C >115 mg/dl, systolic blood pressure >140 mmHg and BMI >28

Assessed as net improvement in Framingham Risk Score (number of subjects who reduced the score minus number of subjects who increased the score)